HIGHLIGHTS
- who: Hany E. Marei from the (UNIVERSITY) have published the research work: Multimodal targeting of glioma with functionalized nanoparticles, in the Journal: (JOURNAL)
- what: The existence of BBBs and their immunosuppressive nature are the main reasons for their failure.
- future: More optimization of the SNA platform as well as additional testing in animal models of human glioblastoma will be required before moving into patients.
SUMMARY
The general strategies for glioma targeting delivery of a systemically administered NPs-based brain-targeting drug delivery system include a six-step CRITID delivery . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.